Evidence map›Paper›PMID 42205718›Full record

ArticleJournal of transplantation2026

A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients.

Afolarin A Otunla, Ailey McLeod, Katie Gilchrist, Cecilia Vindrola-Padros, Reza Motallebzadeh

Abstract read
In one paragraph

Article in Journal of transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Afolarin A OtunlaResearch Department of Surgical Biotechnology, University College London, London, NW3 2PP, UK, ucl.ac.uk.ORCID https://orcid.org/0000-0002-9091-7853
Ailey McLeodDepartment of Targeted Intervention, University College London, London, W1W 7TY, UK, ucl.ac.uk.
Katie GilchristDepartment of Targeted Intervention, University College London, London, W1W 7TY, UK, ucl.ac.uk.ORCID https://orcid.org/0000-0002-8529-4997
Cecilia Vindrola-PadrosDepartment of Targeted Intervention, University College London, London, W1W 7TY, UK, ucl.ac.uk.
Reza MotallebzadehResearch Department of Surgical Biotechnology, University College London, London, NW3 2PP, UK, ucl.ac.uk.ORCID https://orcid.org/0000-0002-5399-9546

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To assess the experiences of CMV among kidney transplant recipients in a single transplant centre, focusing on their awareness of CMV, the impact of the disease on their quality of life, and their perceived effectiveness of anti-CMV therapy. Subjects/Patients or Materials and Methods: We carried out semistructured interviews with 50 adult recipients who had undergone kidney transplantation within the last two years in our centre. Participants were divided into those who had experienced CMV (CMV group, Results: Awareness of CMV was low, particularly among those who had not experienced the virus. 32% ( Conclusion: This study is the first to provide a comprehensive evaluation of CMV awareness and management from the perspective of kidney transplant recipients in the UK. We highlight a significant gap in CMV awareness among kidney transplant recipients, emphasizing the need for improved educational efforts. Enhanced patient education, particularly through multimedia patient educational tools, could bridge the knowledge gap and ensure better management of CMV in this population. These insights are vital for shaping future patient care strategies and could significantly impact clinical practice, particularly in post-transplant care.

Indexed as

cytomegalovirusexperiencekidney transplantqualitativetreatment

Identifiers

PMID42205718
PMCPMC13202444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.